We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Explainable AI Tool Identifies High-Risk Patients Before Heart Attack Reperfusion

By HospiMedica International staff writers
Posted on 14 Sep 2026

Intramyocardial hemorrhage is bleeding within the heart muscle that can occur after blood flow is restored during heart attack treatment. More...

It affects about 40% of patients treated for ST-segment elevation myocardial infarction (STEMI) and is linked to higher risks of heart failure and death. Clinicians lack a reliable way to anticipate this complication before reopening an occluded artery. Researchers have developed an explainable artificial intelligence score to flag high-risk patients before reperfusion.

State University of New York Upstate Medical University (SUNY Upstate; Syracuse, NY, USA) led the development of an intrinsically explainable AI-based scoring system to estimate the likelihood of intramyocardial hemorrhage before an artery is reopened. The approach is designed for use by interventional cardiologists in cardiac catheterization laboratories. It aims to support decision-making at the point of care for patients presenting with ST-segment elevation myocardial infarction.

The risk score is intended for application during emergency angiography to provide real-time assessment before reperfusion. It can also assist in selecting patients for closer post-procedural monitoring once flow is restored. In addition, the tool may help determine who should undergo cardiac magnetic resonance imaging and who may qualify for clinical trials focused on limiting hemorrhagic injury.

The research describing the model was published in JACC: Advances. Collaborating institutions included the Indiana University School of Medicine, the University of Toledo College of Medicine and Life Sciences, Northern Ontario School of Medicine University, Cleveland Clinic, and Upstate Medical University. The team developed and tested the score to identify patients at high risk of bleeding into damaged heart muscle after a severe heart attack using explainable artificial intelligence.

"This is the kind of AI we need for accurate, interpretable and usable data at the point of care. The SNN method allows interventionalists to see exactly which factors are driving the prediction, rather than being asked to trust a black box," said Ankur Kalra, director of cardiac catheterization laboratories and chief of cardiology at Upstate Medical University. "These findings are actionable in an electronic health record-based calculator that can help identify these patients." 

Related Links
SUNY Upstate Medical University 


Gold Member
Blood Gas Analyzer
i-Check200
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Patient Preoperative Skin Preparation
BD ChloraPrep
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.